Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood

HSP90 inhibitors have been shown to kill Epstein-Barr virus (EBV)-infected cells by reducing the level of EBV EBNA-1 and/or LMP1. We treated virus-infected cells with ganetespib, an HSP90 inhibitor currently being evaluated in multiple clinical trials for cancer, and found that the drug killed EBV-p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Leuk Lymphoma
Egile Nagusiak: Shatzer, Amber, Ali, Mir A., Chavez, Mayra, Dowdell, Kennichi, Lee, Min-Jung, Tomita, Yusuke, El-Hariry, Iman, Trepel, Jane B., Proia, David A., Cohen, Jeffrey I.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6358278/
https://ncbi.nlm.nih.gov/pubmed/27686857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2016.1213823
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak